Ocular Therapeutix (OCUL) EBIT Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 6,993.00 |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -69,686.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69,686.00 |
| Dec 31, 2025 | -38,893.00 |
| Sep 30, 2025 | -29,229.00 |
| Jun 30, 2025 | -34,020.00 |
| Mar 31, 2025 | -46,224.00 |
| Dec 31, 2024 | -14,943.00 |
| Sep 30, 2024 | -13,751.00 |
| Jun 30, 2024 | -9,248.00 |
| Mar 31, 2024 | 6,151.00 |
| Dec 31, 2023 | 5,971.00 |
| Sep 30, 2023 | 11,095.00 |
| Jun 30, 2023 | 100,438.00 |
| Mar 31, 2023 | 46,819.00 |
| Dec 31, 2022 | 81,107.00 |
| Sep 30, 2022 | 261,174.00 |
| Jun 30, 2022 | 316,056.00 |
| Mar 31, 2022 | 386,030.00 |
| Dec 31, 2021 | 328,252.00 |
| Sep 30, 2021 | 281,441.00 |
| Jun 30, 2021 | 192,056.00 |
| Mar 31, 2021 | 368,184.00 |
| Dec 31, 2020 | 241,592.00 |
| Sep 30, 2020 | 266,719.00 |
| Jun 30, 2020 | 304,715.00 |
| Mar 31, 2020 | 266,257.00 |
| Dec 31, 2019 | 149,208.00 |
| Sep 30, 2019 | -85,511.00 |
| Jun 30, 2019 | -80,433.00 |
| Mar 31, 2019 | -146,933.00 |
| Dec 31, 2018 | -82,130.00 |
| Sep 30, 2018 | 2.43 Mn |
| Jun 30, 2018 | 592.00 |
| Mar 31, 2018 | -96,870.00 |
| Dec 31, 2017 | -111,663.00 |
| Sep 30, 2017 | 183,292.00 |
| Jun 30, 2017 | 194,291.00 |
| Mar 31, 2017 | 2.20 Mn |